Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study

Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study

Diabetes mellitus (DM) is a chronic metabolic disease which is independently associated with unfavorable clinical outcomes in patients with atrial fibrillation (AF). Few real-world data are available about the clinical performance of non-vitamin K oral anticoagulants (NOACs) among patients with atri...

Full description

Bibliographic Details
Main Authors: Vincenzo Russo, Emilio Attena, Anna Rago, Enrico Melillo, Pierpaolo Di Micco, Andrea Antonio Papa, Giovanni Napolitano, Antonio D’Onofrio, Paolo Golino, Gerardo Nigro
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Clinical Medicine
Subjects:
direct oral anticoagulants
edoxaban
atrial fibrillation
diabetes mellitus
stroke prevention
bleeding risk
Online Access:https://www.mdpi.com/2077-0383/9/6/1621

Internet

https://www.mdpi.com/2077-0383/9/6/1621

Similar Items